Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Randomised Double-Blind Placebo-Controlled Study of Multiple Ascending Dose of KBL693 in Healthy Participants

NCT04307173 is registered in ClinicalTrials.gov with KoBioLabs as lead sponsor.

NCT NCT04307173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04307173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Randomised Double-Blind Placebo-Controlled Study of Multiple Ascending Dose of KBL693 in Healthy Participants
Lead sponsor
KoBioLabs
Phase
Phase 1
Overall status
Completed
Start date
August 14, 2020
Completion date
November 12, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe asthma